Clinical Trial Update: Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the preliminary performance of the C13-URA Breath Test Kit in dyspeptic subjects (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia

Drugs mentioned

• C13-URA Breath Test Kit

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Dyspeptic Subjects | Phase 2 | Status: COMPLETED